Syllable

Syllable

AI-driven healthcare information access solutions

About Syllable

Simplify's Rating
Why Syllable is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$81.7M

Headquarters

Sunnyvale, California

Founded

2017

Overview

Syllable.ai focuses on improving the healthcare industry by using artificial intelligence and machine learning technologies. The company provides an enterprise assistant that helps healthcare organizations access information more easily and improve their operations. This tool uses natural language processing to analyze text and voice data, which helps in making better decisions and enhancing patient care. Syllable.ai's services are subscription-based and tailored for healthcare providers, allowing them to access important information about medical practices and medications. A significant advantage of Syllable.ai's technology is its ability to lower service costs, with many organizations reporting over a 50% reduction in expenses after implementation. The goal of Syllable.ai is to enhance access to healthcare information and services, ultimately benefiting both patients and healthcare providers.

Simplify Jobs

Simplify's Take

What believers are saying

  • Syllable raised $40M in Series C funding to enhance their AI solutions.
  • They were named a top digital front door company by AVIA Marketplace in 2024.
  • Syllable's acquisition of Actium Health optimizes patient volume and reduces staff burden.

What critics are saying

  • Increased competition from AI healthcare startups like Olive and Qventus.
  • Integration of Actium Health may cause operational challenges and cultural clashes.
  • Rapid AI advancements require costly updates to maintain competitiveness.

What makes Syllable unique

  • Syllable uses AI to improve patient access and reduce healthcare service costs.
  • Their enterprise assistant democratizes access to healthcare information efficiently.
  • Syllable's solutions are trusted by major healthcare providers across the U.S.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$81.7M

Meets

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Below Average

Industry standards

$50M
$40M
Syllable
$50M
Medium
$62M
SeatGeek
$100M
Oura

Growth & Insights and Company News

Headcount

6 month growth

↓ -19%

1 year growth

↓ -5%

2 year growth

↑ 0%
Business Wire
Mar 21st, 2024
Syllable Corporation Announces Purchase of Actium Health

Syllable, (www.syllable.ai), a leader in healthcare artificial intelligence and process automation, today announced its purchase of Actium Health. Act

Business Wire
Mar 20th, 2024
Syllable Corporation Announces Purchase Of Actium Health

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Syllable, (www.syllable.ai), a leader in healthcare artificial intelligence and process automation, today announced its purchase of Actium Health. Actium Health will operate as a division of Syllable Corporation. As the industry evolves, health systems are faced with multiple challenges: Revenue growth with limited capacity, managing and retaining a highly-skilled, but burnt-out workforce, increasing operational costs, and making the most of their care delivery capacity to ensure patient access to high-quality care. Together, Syllable and Actium Health provide AI-driven automation solutions that enable health systems to optimize patient volume/capacity, reduce staff burden, and deliver improved patient access and outcomes. This makes it possible for health systems to ensure access for all patients, but especially for those who need care the most, such as patients at highest risk for chronic conditions such as breast cancer and heart disease

Business Wire
Feb 22nd, 2024
Syllable Named To Avia Marketplace’S 2024 Top Digital Front Door Companies

SUNNYVALE, Calif.--(BUSINESS WIRE)--AI-enabled healthcare automation leader Syllable announced today that it was recognized as a 2024 Top Company in Digital Front Door upon conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace. Leveraging artificial intelligence (AI) and natural language processing (NLP), Syllable's Patient Assistance helps patients easily and quickly navigate health care inquiries with empathy, transparency and intelligence from the moment they request care by dialing the phone or visiting a health system's website. For healthcare consumers, Patient Assistant accelerates access to care while improving patient experience and satisfaction. For healthcare systems, Patient Assistant accelerates service line revenue growth while reducing operational costs and staff burnout. “We are thrilled to be named one of AVIA Marketplace’s top digital front door companies. Syllable has demonstrated our ability to improve the patient experience for 6 years with leading health systems in the US

YouTube
Dec 22nd, 2022
Paul Joiner

In this inaugural episode Syllable Corporation welcomed Paul Joiner, the CEO of Kipu Health, to the podcast.

Passionate Pioneers
May 3rd, 2022
Syllable Corporation hires Adam Silverman as Chief Medical Officer

Dr. Adam Silverman, Chief Medical Officer at Syllable, joins Syllable Corporation to discuss how he and his team are helping healthcare providers remove communication barriers between patients and the care they need through conversational AI.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Syllable right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →